T36.92 Poisoning by unspecified systemic antibiotic, intentional self-harm

Name of the Condition

• Poisoning by unspecified systemic antibiotic, intentional self-harm

Summary

This condition involves intentional self-harm resulting from exposure to an unspecified systemic antibiotic, leading to poisoning. It applies when a patient intentionally ingests, administers, or exposes themselves to a systemic antibiotic, causing harmful effects. Documentation should specify the intentional nature of the event and note the lack of identification of the specific antibiotic involved.

Causes

Intentional self-harm poisoning may result from deliberate overdose, self-administration of antibiotics without medical indication, or intentional exposure to antibiotics. This can occur due to suicidal ideation, self-injurious behavior, or attempts to manipulate therapeutic outcomes. Adverse effects may stem from allergic reactions or idiosyncratic responses to the antibiotic.

Risk Factors

• Prior history of mental health conditions (e.g., depression, anxiety).
• Access to medications without supervision.
• History of substance use or misuse.
• Social or environmental stressors contributing to self-harm behaviors.
• Lack of support systems or mental health resources.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis (if allergic to the antibiotic).
• Systemic: Fever, hypotension, organ dysfunction (e.g., nephrotoxicity).
• Neurological: Dizziness, confusion, or seizures in severe cases.
• Metabolic: Electrolyte imbalances or acid-base disturbances.

Diagnosis

Evaluation includes patient history of antibiotic exposure, intent, and clinical presentation. Laboratory tests may assess antibiotic levels, organ function (e.g., renal, hepatic), and metabolic status. Toxicology screening can help identify the antibiotic involved, though the code applies when unspecified. Imaging or other diagnostic tools may be used to assess complications.

Treatment Options

Management focuses on stabilizing the patient, removing the antibiotic (e.g., gastric lavage, activated charcoal), and addressing symptoms. Supportive care includes monitoring vital signs, fluid resuscitation, and treating allergic reactions or organ dysfunction. Psychological evaluation and intervention are critical for addressing self-harm behaviors. Specific antidotes or treatments depend on the antibiotic and clinical findings.

Prognosis and Follow-Up

Prognosis varies based on the antibiotic, dose, and timely intervention. Early treatment improves outcomes, while severe toxicity or delayed care may lead to complications. Follow-up includes monitoring for organ damage, psychological support, and addressing underlying mental health concerns. Long-term care may involve therapy, medication management, or safety planning.

Complications

• Organ damage (e.g., kidney, liver) from toxicity.
• Severe allergic reactions or anaphylaxis.
• Metabolic disturbances (e.g., electrolyte imbalances).
• Neurological sequelae (e.g., seizures, cognitive impairment).
• Psychological impacts or recurrent self-harm.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on safe medication handling and disposal.
• Mental health support and crisis intervention resources.
• Regular monitoring for at-risk individuals.
• Collaboration with healthcare providers to address underlying conditions.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with antibiotics is suspected or confirmed. Signs of severe reaction (e.g., difficulty breathing, seizures, loss of consciousness) require urgent care. Follow up with mental health professionals for ongoing support and risk assessment.

Tips for Medical Coders

Document the intentional self-harm nature of the event and the unspecified antibiotic clearly. Include details about the encounter (e.g., initial, subsequent) and any associated symptoms or treatments. Ensure the code aligns with clinical documentation to reflect the intentional intent and lack of specific antibiotic identification.